CHATSWORTH, Calif., Jan. 26 -- Natrol, Inc. (NASDAQ:NTOL) , a manufacturer and distributor of nationally branded nutritional products, announced it has entered into an agreement with 12-time NBA All-Star and NBA Hall of Fame member Earvin "Magic" Johnson to promote their immune enhancing products.
"Nutrition is obviously a very important component to my health and the health of those in our community," stated Mr. Johnson. "I've been searching for a leader in the nutrition industry for some time. Natrol is a quality company with a unique immune enhancing product and I want to help spread the word."
Retired from the NBA, Johnson is recognized for building successful businesses and increasing jobs in urban areas across the country, and he has been an outstanding spokesperson for health and fitness. He will be a part of a communications program supporting ImmunEnhancer AG, a novel natural ingredient found in products such as Natrol's My Defense(R).
"We are delighted to be working with Mr. Johnson," commented Elliott Balbert, Natrol President and CEO. "'Magic' will bring a new level of awareness to the explosive immune support nutritional category."
Natrol My Defense(R) is a nutritional supplement that includes the natural ingredient ImmunEnhancer AG. It enhances natural killer cell activity* and promotes healthy immune function*. More information can be found at www.natrol.com.
ImmunEnhancer AG is marketed exclusively by Essentially Pure Ingredients, a division of Natrol, under license from Larex, Inc. www.essentiallypure.com.
The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, including the factors described above and factors that the Company may not currently foresee, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2002 and in the Company's other filings with Securities and Exchange Commission, the Company's actual results could differ materially from those set forth in the forward-looking statements.
* These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.